Senior insider sale
Chief Executive Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$2.98M
200K shares
What this filing means
SANTOS DA SILVA JORGE plans to sell 200K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $2.98M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001969223-25-001045
DirectorOfficer· Chief Executive Officer
Since Apr 2022
200K
Shares to sell
$2.98M
Approx. market value
3.17M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exchange of shares
Exchange
10/1/2023
140.07KExchange of Shares
Exchange
10/1/2023
3.03MTotal acquired3.17M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2023 | Exchange of shares Exchange | 140.07K | — |
10/1/2023 | Exchange of Shares Exchange | 3.03M | — |
| Total | 3.17M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
200K
Market value
$2.98M
12/8/2025
Total
Units
200K
Value
$2.98M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/8/2025 | 200K | $2.98M | Nasdaq | Planned |
| Total | 200K | $2.98M | ||